Suicide Awareness: Stories of Hope & Recovery
A FREE public health talk on suicide awareness on September 28, 2016
September 2016, Toronto, ON – David and Deborah Cooper, suicide loss survivors, will join CAN-BIND and St. Michael’s Hospital scientist Dr. Sakina Rizvi for the Distinguished Speakers Series: Suicide Awareness – Stories of Hope & Recovery, a free public talk on suicide awareness from a lens of hope and recovery.
The Coopers are suicide loss survivors following the death of their son Eli Cooper in 2010. They will share the story of their family’s journey of hope and recovery. They are working to establish Eli’s Place, a rural residential treatment centre for young adults with serious mental illness. Dr. Rizvi is a neuroscientist at CAN-BIND and will present research on identifying biological and behavioural risk factors for suicide and treatment resistant depression in order to predict treatment outcomes. Together, they will bring their unique knowledge of mental illness to bring awareness to suicide.
The Distinguished Speakers Series is an ongoing event presented by the Mood Disorders Association of Ontario and CAN-BIND. The series brings people with lived experience and researchers together to discuss mental health issues.
Distinguished Speakers Series: Suicide Awareness – Stories of Hope & Recovery will take place on Wednesday September 28, 2016 from 7-9 p.m. (doors open at 6:30) at the Li Ka Shing Knowledge Institute, Auditorium Room 209, 209 Victoria St., Toronto, ON Auditorium Room 209. The event is open to the general public. To register for this free event, visit http://hopeandrecovery.eventbrite.ca/.
A panel discussion will take place after the keynote speakers with an opportunity for questions from the audience.
Mood Disorders Association of Ontario (MDAO):
The Mood Disorders Association of Ontario is a leader in group-based and one-on-one peer support for individuals living with mood disorders and their families. As an Ontario-wide community-based organization, our efforts are guided by lived experience, and an overarching belief in the ability of individuals and families affected by depression, anxiety, or bipolar disorder to recover and heal. We work within a recovery oriented framework in hopes of helping individuals along in their journey.
The Canadian Biomarker Integration Network for Depression (CAN-BIND):
CAN-BIND aims to reduce the impact of depression and its treatment by identifying “biomarkers”; these are biological and clinical characteristics that will help guide treatment selection. They do this by conducting a cross-Canada study of people being treated with standard medication for depression, but also getting a variety of blood tests, questionnaires, and MRI scans. The CAN-BIND study aims to take the guess work out of psychiatric treatment for depression by finding clear and objective ways of matching the right treatment to the right patient for various types of depression.
For more information, or to request an interview, contact Andrew Kcomt at the Mood Disorders Association of Ontario. Email: email@example.com or 1-416-486-8046 ext. 246.